Video
Addressing the Efficacy of Perioperative Octreotide for Carcinoid Crisis in Patients with Neuroendocrine Tumors
Rodney Pommier, MD, FACS, professor of surgery, division of surgical oncology, school of medicine, Oregon Health & Science University, addresses the questions surrounding the efficacy of perioperative octreotide treatment for patients experiencing a carcinoid crisis.
Pharmacy Times interviewed Rodney Pommier, MD, FACS, professor of surgery, division of surgical oncology, school of medicine, Oregon Health & Science University, on his presentation at the 2021 NANETS Multidisciplinary Neuroendocrine Tumors (NETs) Medical Virtual Symposium discussing a prospective study of carcinoid crisis with no perioperative octreotide.
During the interview, Pommier addressed the questions surrounding the efficacy of perioperative octreotide treatment for patients with NETs experiencing a carcinoid crisis and why these questions were important to investigate.
